DCM Nouvelle Board of Directors
Get the latest insights into the leadership at DCM Nouvelle. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Meenakshi Nayar | Chairperson & Independent Director |
| Mr. Hemant Bharat Ram | Managing Director |
| Mr. Rakesh Goel | Non Exe.Non Ind.Director |
| Dr. Vinay Bharat Ram | Whole Time Director |
| Mr. Jitendra Tuli | Non Exe.Non Ind.Director |
| Mr. Kulbir Singh | Independent Director |
| Mr. Vivek Chhachhi | Independent Director |
DCM Nouvelle Share price
DCMNVL
163.78
0.65 (0.40%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High
173.82
Today's Low
161.30
52 Week Low
145.00
52 Week High
241.79
The current prices are delayed, login to your account for live prices
LoginDCM Nouvelle FAQs
The board at DCM Nouvelle consists of experienced professionals, including Dr. Meenakshi Nayar , Mr. Hemant Bharat Ram , and others, overseeing the company’s strategic and corporate governance.
Directors at DCM Nouvelle are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Meenakshi Nayar is the current chairman at DCM Nouvelle.
Executive directors at DCM Nouvelle are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, DCM Nouvelle adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At DCM Nouvelle, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.